On this week’s Trending News EU episode, Jack, Gemma, and Adrien share their insights from the recent Reuters Pharma 2023 conference held in Barcelona including the latest developments on Digital Health (1.51), Medical Affairs (3.50), Patient Engagement (7.11), and the perspectives from pharma leaders who attended Vynamic’s roundtable on patient initiative impact measurement (10.06)
Podcast Tags: healthcare, pharma, digital health, medical affairs, patient engagement, omnichannel patient experience, metrics, impact
Source Links:
Pharma 2023 (reutersevents.com)
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at
1-888-VYNAMIC.
Jen Burke, Healthcare Industry Strategist
Jack Young, Senior Director
Gemma Pfister, Senior Executive
Adrien Moucquot, Senior Director
25 May 2023
4 May 2023
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Colleen Lawlor
Bring clarity to complexity and ensure a successful Alliance Launch with a cohesive culture, streamlined processes, and efficient asset management.
Read moreIn this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe,...
Listen nowIn recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to...
Listen now